Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 601 50 161.6 |
96 | EP file number | EAKZ | 10 01 0997.4 |
97 | EP publication number | EPN | 2298348 |
54 | Designation/title | TI | Antikörper gegen Alpha4beta7 Integrin und sein Verwendung zur Behandlung von Darmerkrankungen |
51 | IPC main class | ICM (ICMV) | A61K 39/395 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/635 (2006.01), A61K 31/60 (2006.01), A61K 31/57 (2006.01), A61K 31/52 (2006.01), A61P 37/06 (2006.01) |
22 | DE application date | DAT | Apr 13, 2001 |
96 | EP application date | EAT | Apr 13, 2001 |
43 | Date of first publication | OT | Mar 23, 2011 |
| Date of publication of grant | PET | Oct 12, 2016 |
71/73 | Applicant/owner | INH | Genentech, Inc., South San Francisco, Calif., US; Takeda Pharmaceutical Co. Ltd., Osaka, JP |
72 | Inventor | IN | Brettman, Lee R., Sudbury, MA 01776, US; Fox, Judith A., San Francisco, CA 94115, US; Allison, David Edward, San Mateo, CA 94403, US |
74 | Representative | VTR | HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
| Address for service | | HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 748960 Dec 27, 2000
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 550082 Apr 14, 2000
|
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 12 2017 000 018.0 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002298348 Searchable text:
EP000002298348 Original document:
EP000002298348B1 Searchable text:
EP000002298348B1 |
43 | Date of first publication | EVT | Mar 23, 2011 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Jun 1, 2023 (Show all update days)(Hide all update days)- Jun 1, 2023; Apr 15, 2021; Mar 18, 2021; Dec 1, 2020; May 5, 2020; Mar 26, 2020; Feb 18, 2020; Feb 5, 2020; Jan 18, 2020; Jan 16, 2020; Sep 7, 2019; Aug 14, 2019; May 10, 2019; May 9, 2019; May 18, 2018; Oct 26, 2017; Sep 21, 2017; May 18, 2017; May 11, 2017; Dec 7, 2016; Nov 10, 2016; Oct 14, 2016; Oct 13, 2016; Aug 4, 2016; Feb 15, 2013; Dec 8, 2011
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 9)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Mar 17, 2021 |
| Issue number | HN | 16 |
| Year | PJ | 2021 |
| Publication date | VT | Apr 22, 2021 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Genentech, Inc., South San Francisco, Calif., US; Takeda Pharmaceutical Co. Ltd., Osaka, JP |
71/73 | Previous applicant/owner | INHF | Genentech, Inc., South San Francisco, Calif., US, Millennium Pharmaceuticals, Inc., Cambridge, Mass., US |
| Date of update of the procedure | REGT | Apr 15, 2021 |